CYP2A6 interacts_with nicotine replacement therapy
Evidence from:
primary |
all sources
Evidence (1 sources)
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.
(2012)
PMID:22290489
cited
The correlation between CYP2A6 genotypes and withdrawal symptoms was more notable in smokers who used NRT.
confidence: 0.90